ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2021
Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective.
Anders Grubb et al.PubMed ↗Publisher ↗
No numbers read from the abstract.